Braille for medicinal products
On 15 January 2013 ISO 17351 was published. This standard specifies requirements and provides guidance for the application of Braille to the labelling of medicinal products. This standard is based on NEN-EN 15823. The labelling of medicinal products placed on the market and incorporating Braille in accordance with this European Standard meets the requirements of European Directive 2001/83/EC, Article 56, (a) as amended by Directive 2004/27/EC. The ISO standard was prepared by Technical Committee 122 Packaging Working Group 9 Accessible Design. This working group will hold their next meeting on March 6th and 7th in Gouda. On March 5th, the day before the ISO-meeting, NVC is hosting the 2nd World Seminar on Accessible and Inclusive Design in Packaging in Gouda. Accessible (inclusive) design addresses the need to enable as many people as possible to do so safely, effectively and easily. As the world population is getting older and a great diversity of products are even more widely distributed, accessibility (inclusivity) is evolving into a driver for business success in the market of packaged products (World Packaging Standardisation Newsletter, January 2013).